Response to Stoll and Resta

Comment

Gabriel A Lazarin et al. Genet Med. 2013 Apr.

. 2013 Apr;15(4):319-20.

doi: 10.1038/gim.2013.19.

No abstract available

Comment on

An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals.
Lazarin GA, Haque IS, Nazareth S, Iori K, Patterson AS, Jacobson JL, Marshall JR, Seltzer WK, Patrizio P, Evans EA, Srinivasan BS. Lazarin GA, et al. Genet Med. 2013 Mar;15(3):178-86. doi: 10.1038/gim.2012.114. Epub 2012 Sep 13. Genet Med. 2013. PMID: 22975760 Free PMC article.
Considering the cost of expanded carrier screening panels.
Stoll K, Resta R. Stoll K, et al. Genet Med. 2013 Apr;15(4):318-9. doi: 10.1038/gim.2013.18. Genet Med. 2013. PMID: 23552453 No abstract available.

1. Stoll K, Resta R. Considering the cost of expanded carrier screening panels. Genet Med. 2013;15:318–319. doi: 10.1038/gim.2013.18. - DOI - PubMed
1. Wilson JM, Jungner YG. Principles and Practice of Screening for Disease. World Health Organization: Geneva; 1968.
1. Dietz HC. New therapeutic approaches to mendelian disorders. N Engl J Med. 2010;363:852–863. doi: 10.1056/NEJMra0907180. - DOI - PubMed
1. Lewis C, Skirton H, Jones R. Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing? J Genet Couns. 2011;20:80–97. doi: 10.1007/s10897-010-9327-8. - DOI - PubMed